*Registration   *Agenda   *Faculty   *CE Credit  

Course Description and Target Audience
No one is immune from the medical, regulatory and social challenges associated with managing the chronic pain patient type.  This symposium is designed to build awareness and collaboration among healthcare providers and regulators affiliated with chronic pain management. As the landscape of healthcare continues to change, the mission of the Kentucky Pain Society is to provide education and resources to physicians and their support staff that will encourage high quality patient care while maintaining a high standard of medical and regulatory accountability.  We hope to educate, inspire and motivate as well as be the change we wish to see in today’s challenging chronic pain management arena.

The target audience will include Primary Care Physicians throughout the state of Kentucky as well as those in Other Specialties who provide Pain Management Services.

Agenda                                                                              
7:00 AM   
Registration/Continental Breakfast/Exhibits

7:45 AM   
Welcome & Introduction
Kendall Hansen, M.D.

7:50 AM   
A Message on Healthcare Today/Health Information Technology/Physician Advocacy
Lt. Gov. Dan Mongiardo

8:00 AM   
National Pharmaceutical & Diversion Trends
Mark W. Caverly

8:40 AM      
How Healthcare Insurance Benefits Finance Abuse of Controlled Substances       
Dennis Luken

9:15 AM    
Top 10 Questions We are Asked and M.D. Mistakes that Get Them Into Trouble       
Steve Hart

9:35 AM    
Break/Exhibits

9:45 AM     
Your Medical Practice & Compliance with the DEA
Robert Otero
Frank Younker

10:00 AM     
The Role of Local Regulatory Bodies/NKY Drug Strike Force       
Terry Towles

10:15 AM
Roundtable of all Speakers Listed Above - Audience Time to Ask Questions Regarding Content Discussed/Case
Studies Applied

10:45 AM     
How Do Interventional Pain MGMT Physicians Prescribe Opioids? How Can Interventional Therapy Decrease Opioid Dependence?
Kendall Hansen, M.D.
Jose Rivera, M.D.
Sung Min, M.D.

11:30 AM   
Lunch/Exhibits

12:30 PM      
Methadone & Opioid Prescribing in a Storm of Abuse & Diversion
John Peppin, M.D.

1:30 PM      
Office Based Opiate Toxicology Testing Implementation & Accruacy
Robert Klickovich, M.D.

2:00 PM 
Sleep, Psychology, & Pain
Jonathan Cole, Ph.D

2:30 PM       
Break/Exhibits

2:45 PM     
Saboxone Therapy
Gary Shearer, M.D.

3:30-5:05 PM   
Complex Chronic Pain Management Clinical Case Study & Treatment Plan Development Covering Medical, Social, and Regulatory Facets - Presented By KPS Faculty with Audience Participation

Faculty
Kendall E. Hansen, M.D.
President KY Pain Society
Assoc. Member ASIPP
Medical Director/Owner Interventional Pain Specialists

Jose Rivera, M.D.
Management Physician
Pain Management Center Of Paducah
Board Member
Center For Pain Management

Sung K. Min, M.D.
Chief Resident
Chief Fellow
Interventional Pain Specialists    

Daniel Mongiardo, M.D.
KY Lt. Gov.
Chief Of Staff ARH

Mark W. Caverly
Chief Liaison
Policy Section Office of Diversion Control
DEA

Dennis Luken   
President
Pharmaceutical Diversion Resources 
Board Member
National Association of Drug Diversion Investigator

Steve Hart
Pharmacy Inspection 
Investigation Coordinator
KY Board of Pharmacy 

Frank Younker     
Agent/Supervisor
DEA

Robert Otero     
Agent/Supervisor
DEA

Terry Towles
Agent
Northern Kentucky Drug Strike Force

John Peppin, M.D.
Director
Clinical Research Pain Treatment Center of Bluegrass 
Clinical Assoc Professor 
University of KY
Associate Medical Director
Hospice Bluegrass

Robert Klickovich, M.D.
Harvard Medical School Graduate
M.D. Interventional Pain Specialists

Jonathan Cole, Ph.D.   
President
Bluegrass Health Psychology
Board Member
Southern Pain Society

Gary Shearer, M.D.   
Gary A Shearer M.D. Family Practice LLC 
Board Certified
American Society of Addiction Medicine

Continuing Education Credit
Physician Credit - The University of Louisville Continuing Health Sciences Education office designates this educational activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nursing Credit - This program has been approved by the Kentucky Board of Nursing for 9.4 contact hours through the University of Louisville School of Nursing, provider number 3-0046-01-2013-105, expiration date January 31, 2013. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Participants must complete entire session, provide license and social security number and complete evaluation to receive contact hours.

Psychology - The Kentucky Board of Psychology has approved this program for 8.0 Continuing Education Units.

AAFP - This activity has been reviewed and is acceptable for up to 8.0 prescribed credits by the American Academy of Family Physicians.

Registration
Registration Fees:
Physicians, $175
Nurses, $125
U of L Faculty, $125
U of L students, $125
U of L Residents, $125
All Others, $125

To Register, please contact Lee Ann Taylor: 513-476-2291 or

LTaylor@ipainspecialists.com

 To Register online: www.kypainsociety.org

Parking

 On-site parking, fee: $1.50 hourly, $12 daily

Valet parking, fee: $22 daily

Off-site parking, fee: $1.50 hourly, $8 daily

For more parking information, please call the Marriott River Center:  1-800-266-6605


Driving Directions

For driving directions, go to http://www.mapquest.com


Learning Objectives & Outcomes

1) Decide patient needs while doing due diligence to protect the community from diversion and illicit use as well as follow regulatory guidelines.

2) Act with confidence when prescribing opioids.

3) Obtain the entire patient story, including H&P, diagnostic tests, & diversional/abuse screening mechanisms to provide proper high-quality chronic pain treatment plans to the chronic pain patient type.

4) Capture several treatment modalities for chronic pain management & recognize that opioid prescribing is only one tool for the management of this patient type.

5) Assess various medical opinions regarding chronic pain treatments & determine what works best for you and your patient.

6) Evaluate the educational background of those treating chronic pain patients and what this means to the specialty of pain management and the patient receiving the plan of care.

7) Implement appropriate opioid prescribing action items, including: toxicology screening, prescription drug monitoring, proper documentation procedures & staff training.

8) Recognize the pharmacokinetics & clinical relevance of methadone & saboxone.

9) Describe the terms regarding proper execution of urine drug testing.

10) Comprehend the relationship between pain and sleep and the role pain medications play with sleep architecture.

11) Verbalize the evolution of illicit, prescription analgesic, anxiolytic, and hypnotic drug use in the U.S. from 1960’s to present.

12) Discuss the current teen attitudes/views of prescription drug use.

13) Identify current national & regional scope & extent of narcotic analgesics, benzodiazepines, hypnotic & illicit substances for non medical purposes.

14) Differentiate between the national forensic laboratory information system, office of national drug control policy and substance abuse & mental health services administration for data tracking & information support regarding narcotic analgesics, anxiolytics, hypnotics, and illicit substance abuse.

15) Recognize the quantity sold & how the following are being used for non medical purposes: hydrocodone / apap, oxycodone, alprazolam, methadone, hydromorphone, fentanyl, dilaudid, kadian, avinza, soma, ms contin, xanax, Demerol, Tylenol #3, diazepam, darvocet, palladone, Ritalin, stadol nose spray, proventil, ultram, adipex, sleeping medications.

16) Discover regional injury trends r/t unintentional poisoning & overdose incidents with narcotic analgesics.

17) Assess impact of internet drug diversion, including role of internet pharmacies & # of dosages dispensed.

18) Distinguish the drugs most abused in today’s workplace which are obtained through health insurance.

19) Review the cost opioid abusers have on healthcare insurers per patient versus the legitimate chronic pain patient.

20) Recognize the systemic supply chain between healthcare providers, pharmacies, law enforcement, abusers, & traffickers as well as know what constitutes deception by this patient type and when the patient/doctor confidentiality agreement ends.

21) Describe the measures provided to protect the physician practice from prescription drug diversion.

22) Cite specific examples delivered by prescribing physicians which contributed to prescription drug abuse and diversion per the KY state pharmacy board.

23) Identify the role of the local DEA and other regulatory bodies, such as NKY drug strike force and the resources/support offered to combat prescription drug abuse and diversion.


Special Services
If you need special accommodations due to a disability, or for an alternative form of course materials, please contact us at chse@louisville.edu. Continuing Health Sciences Education fully complies with the legal requirements of the ADA and the rules and regulations thereof.


Joint Sponsor Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the
Accreditation Council for Continuing Medical (ACCME) through the joint sponsorship of the University of
Louisville and the Kentucky Pain Society. The University of Louisville is accredited by the ACCME to provide continuing medical education for physicians.